Form 424B2 Oxford Lane Capital Corp
http://archive.fast-edgar.com/20261021/A42TT22DLC22D2B2222A2CY29RODZ222E282
Filed on: October 21, 2026
Form 8-K Imunon, Inc. For: Oct 20
false
0000749647
0000749647
2026-10-20
2026-10-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities... (continue reading...)
Form 3 Virax Biolabs Group Ltd For: Oct 05 Filed by: Monteil Clement
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 8-K Voyager Therapeutics, For: Oct 20
false 0001640266 0001640266 2026-10-20 2026-10-20
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 20, 2026
Voyager Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-37625 46-3003182
(State or other... (continue reading...)
Form 8-K UNIFIRST CORP For: Oct 21
FALSE000071795400007179542026-10-212026-10-21UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549________________________________________________________FORM 8-K________________________________________________________CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): October 21, 2026________________________________________________________UNIFIRST CORPORATION(Exact name... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K UDR, Inc. For: Oct 21
-
Form 8-K Getty Images Holdings, For: Oct 20
-
Form 8-K Zedge, Inc. For: Oct 21
-
Form 6-K MINISO Group Holding For: Oct 21
-
Form 6-K Masonglory Ltd For: Oct 21
-
Form 8-K MILLERKNOLL, INC. For: Oct 20
-
Form D MY PE Access Polymarket
-
Form 8-K Aptera Motors Corp For: Oct 16
-
Form 4 Uxin Ltd For: Oct 20 Filed by: Dai Kun
-
Form 6-K NewGenIvf Group Ltd For: Oct 21
-
Form 6-K Cellyan Biotechnology For: Oct 21
-
Form 8-K Strive, Inc. For: Oct 21
-
Form 13F-HR Ocean Park Asset Managem For: Sep 30
-
Form 8-K ORRSTOWN FINANCIAL SERVI For: Oct 20
-
Form 8-K WINNEBAGO INDUSTRIES For: Oct 21
-
Form 13F-NT HSBC Global Asset Manage For: Sep 30
-
Form 8-K Cencora, Inc. For: Oct 21
-
Form 13F-HR Livforsakringsbolaget For: Sep 30
-
Form SC TO-I INVE Technologies, Inc. Filed by: INVE Technologies, Inc.
-
Form 8-K FLORIDA POWER & LIGHT For: Oct 21 Filed by: NEXTERA ENERGY INC
-
Form 8-K ABBOTT LABORATORIES For: Oct 21
-
Form 8-K M/I HOMES, INC. For: Oct 21
-
Form 6-K Green Circle Decarbonize For: Oct 21
-
Form 4 Valens Semiconductor For: Oct 19 Filed by: Rozenberg Haine Yael
-
Form 6-K SASOL LTD For: Oct 21
-
Form 4 OBOOK HOLDINGS INC. For: Oct 19 Filed by: WANG CHUN KAI
-
Form 8-K Pine Tree Acquisition For: Oct 21
-
Form 8-K Soluna Holdings, Inc For: Oct 21
-
Form 6-K STANTEC INC For: Oct 21
-
Form 8-K Worthington Steel, Inc. For: Oct 21
-
Form 8-K INVE Technologies, Inc. For: Oct 21
-
Form 8-K TELEDYNE TECHNOLOGIES For: Oct 21
-
Form 8-K CME GROUP INC. For: Oct 21
-
Form 13F-NT Quilter Cheviot Internat For: Sep 30
-
Form 424B2 TOYOTA MOTOR CREDIT CORP
-
Form 13F-HR Bellecapital Internation For: Sep 30
-
Form 13F-NT Quilter Investors LTD For: Sep 30
-
Form 8-K WESTINGHOUSE AIR BRAKE For: Oct 21
-
Form 8-K OLD NATIONAL BANCORP For: Oct 21
-
Form 8-K Roivant Sciences Ltd. For: Oct 21
-
Form 13F-NT Quilter Cheviot Ltd For: Sep 30
-
Form 8-K Philip Morris Internatio For: Oct 21
-
Form 8-K HEALTHCARE SERVICES GROU For: Oct 21
-
Form 8-K Genprex, Inc. For: Oct 21
-
Form 6-K NATUZZI S P A For: Oct 21
-
Form 13F-NT Quilter Cheviot Europe For: Sep 30
-
Form 6-K GOWell Energy Technology For: Oct 21
-
Form 8-K STIFEL FINANCIAL CORP For: Oct 21
-
Form SCHEDULE 13D Blackstone Long-Short Filed by: Saba Capital Management, L.P.
-
Form 6-K RedHill Biopharma Ltd. For: Oct 21
